MATHEMATICAL MODELING FOR THE TRANSMISSION DYNAMICS FOR THE TRACHOMA INFECTION WITH TEMPORARY AND PERMANENT BLINDNESS
1A. Alhassan, 2S. Musa and 1A. A. Momoh
1Department of Mathematics, Modibbo Adama University, Yola. Adamawa State.
2Department of Mathematics, Federal University of Agriculture, Mubi. Adamawa State.
Abstract
This study developed a non-linear deterministic model to analyse the transmission dynamics of trachoma. The positivity and boundedness of the model solutions were proven using integration methods alongside the comparison theorem.
The disease-free equilibrium (DFE) was determined, and the basic reproduction number was computed via the next generation matrix method. Local stability was assessed using the Hurwitz criterion and confirmed as being locally asymptotically stable (LAS), while global stability analysis showed the model to be globally asymptotically stable (GAS). ODE45 was used for numerical simulation to examine the effects of treatment, surgery, and vector population management. The model solution's findings show that efforts to treat reversible blindness, control vector populations, and treat and operate on these conditions could significantly aid in reducing the spread of trachoma disease.
INTRODUCTION
Trachoma
Infection typically occurs in the eyelid and may be contracted from direct contact with discharge from the infected area on an infected individual or from contaminated surfaces. Re-infection is very common.
The SAFE consists of:
(trachomatous trichiasis);
Some Assumptions of the Model
Table 3.1(c): Variables for the trachoma model
Parameters | Descriptions | Values | References |
| Human’s recruitment rate | 24.9991 | Muhammad, et. al., (2021) |
| Vector’s recruitment rate | | Muhammad, et. al., (2021) |
| Natural mortality for humans | 0.0014 | Muhammad, et. al., (2021) |
| Natural mortality for vectors | 1.354 | Muhammad, et. al., (2021) |
| Contact rate between the susceptible human with infectious vectors | 0.2903 | Muhammad, et. al., (2021) |
| Contact rate between the susceptible humans with infectious humans | 0.08353 | Muhammad, et. al., (2021) |
| Contact rate between the susceptible vector with infectious humans | 0.07258 | Muhammad, et. al., (2021) |
| Modification perimeter due to less transmission by active stage of trachoma | 0.0017 | Assumed |
| Progression rate from exposed individuals to active stage of trachoma | 0.01212 | Muhammad, et. al., (2021) |
| Rate at which individual who recovered from active trachoma due to treatment | 0.1121 | Muhammad, et. al., (2021) |
| Progression rate from active trachoma to late stage of trachoma | 0.012003 | Muhammad, et. al., (2021) |
| Rate at which individual recovered from late of trachoma due to treatment | 0.3010 | Muhammad, et. al., (2021) |
| Rate at which late trachoma infected individual develops reversible blindness | 0.000361 | Michael (2020) |
| Rate at which individual recovered from infection and reversible blindness | 0.1428 | Muhammad, et. al., (2021) |
| Rate at which individuals become permanently blind | 1.5 | Bako, et, al., (2017) |
| Rate of treatment for individuals who recovered from active trachoma stage | 0.62 | WHO (2014) |
| Rate of treatment for individual recovered from late trachoma stage | 1.25 | Assumed |
| Rate at which individual recovered from trachoma infection and reversible blindness | 1.0 | Assumed |
| Rate at which individual recovered from trachoma infection but remains with blindness | 0.67 | Bako, et, al., (2017) |
| Rate at which individuals becomes permanently blind | 0.0015 | Assumed |
| Rate at which individuals become susceptible after recovery | 0.05 | Michael (2020) |
| Vectors death rate due to spray | 1.0 | Bako, et, al., (2017) |
| Discount Rate | 3% | Momoh et, al., (2021) |
Table 3.1 (d): Variables for the trachoma existing model
Variables | Descriptions |
Sh(t) | Susceptible humans at time |
ET(t) | Exposed humans at time |
AT(t) | Infected humans at early stage of infection at time |
LT(t) | Infected humans at late stage of infection at time |
BT(t) | Temporary blind individuals at time |
BP(t) | Permanently blind individuals at time |
RB(t) | Recovered individuals with permanent blindness at time |
R(t) | Recovered individuals at time |
Sv(t) | Susceptible flies at time |
Iv(t) | Infectious flies at time |
Nh(t) | Human’s total population at time |
Nh(t) | Fly’s total population at time |
TRACHOMA DYNAMIC MODEL
Figure 1: Flow Diagram for the Trachoma Model
Trachoma model equations
Trachoma modified model equations… Continue
RESULTS
Trachoma Model Analysis
Basic properties of the model
The basic properties of the model are explored in order to prove the positivity and boundedness of the model solution.
Positivity of the solution
Theorem
Let the initial data be
Then the solution set
is positive for all time
Proof
Considering equation
We separate the variables, integrate both sides and took the antilog to obtain;
Considering equation;
We separate the variables, integrate both sides and took the antilog to obtain;
Applying similar approach gives;
4.1.1.2 Invariant Region (boundedness)
Theorem 4.2: The solutions to the system with initial conditions and the biological feasible regions
And
so that the regions are positively invariant and attractive.
Proof: we consider the human and the vector populations
Where,
if , then it follows that if
Employing the standard comparison theorem (Lakshmikantham, Leela & Martynyuk, 2000) which was employed using the method of separation of variables to obtain;
Using the method of integrating factor gives;
Particularly, if which implies that the region is positively invariant.
Thus, the model is mathematically well-posed in the domain as the variables used throughout the model, proves to be positive for t > 0. It is therefore, sufficient to consider the dynamics of the flow generated by the model in the domain .
For the vector’s population, we add equations to have;
Where
If then it follows that
Employing the standard comparison theorem (Lakshmikantham, Leela & Martynyuk, 2000) and the method of separation of variables to obtain;
Using the method of integrating factor
Particularly, if , it implies that the region is positively invariant.
Thus, the model is mathematically well-posed in the domain as the variables used throughout the model, proves to be positive for t > 0.
It is therefore, sufficient to consider the dynamics of the flow generated by the model in the domain .
4.1.2 Disease-free equilibrium point
We set the equations to be equal to zero;
And obtain;
In the absence of trachoma;
Therefore, the trachoma-free equilibrium point is given as;
Reproduction Number
The reproduction number is obtained as the most dominant eigenvalues
Local stability of trachoma disease-free
Linearization method has been adopted to analyze the stability of the disease-free equilibrium points of the human and vector’s population. Therefore, the Jacobian matrix of the system was evaluated.
Theorem 4.3
The DFE of the model is locally asymptotically stable (LAS) which has been determined based on the sign of the eigenvalues
Evaluating model equations at DFE and gives;
Finding the eigenvalues gives
The, we obtain the following eigenvalues;
and
Which are all negatives.
After we obtained some of the eigenvalues from (4.1.54), we now have a reduced matrix given as;
(4.1.55)
We carry out elementary row transformation on (4.1.55) in order to obtain the remaining eigenvalues and obatin the following;
The remaining eigenvalues obatined are
The eigenvalues obtained satisfied the condition for local stability.
4.4.4 Global stability of trachoma DFE
We adopt the method used by Castillo-Chavez, et al., (2002) with the following conditions;
Where denotes the uninfected populations and denotes the infected populations respectively.
At DFE, the two conditions that would be met for the global stability are;
is globally asymptotically stable (GAS)
Where A = D2G(Y,0) represents an M-matrix and ∏ is the region where the model makes sense biologically. If the model satisfy the two conditions above then the following theorem holds, (Castillo-Chavez, et al., 2002).
Theorem 4.4
The equilibrium point MT = F(Y* ,0) is GAS.
Proof
We apply theorem 4.4 on the model using condition (i) above.
Condition (i)
It is solved using integrating factor gives;
The values of Sh(0) and Sv(0) where and as
Condition (ii)
Generating and evaluating at DFE gives;
While,
Therefore, going by we have;
Given that 0 < Sh < Nh and 0 < SV < NV are noticeable that and it is also evident that
is GAS. Therefore, by the above theorem MT is GAS.
Figure 2: Graphical Demonstration of the Impact of Treatment
Numerical Simulations
Numerical simulation for the model was carried out using ODE45
Figure 3: Graphical Demonstration of the
Impact of Treatment and Surgery
Impact of Treatment and Surgery on the Transmission Dynamics
Figure 4: Graphical Demonstration of the Impact of Insecticides spray
Impact of Insecticide Spray on the Transmission Dynamics
Discussion of Results
References
Blake, I. M., Burton, M. J., Bailey, R. L., Solomon, A. W., West, S., et al., (2009) Estimating Household and Community Transmission of Ocular Chlamydia trachomatis. PLoS Negl Trop Dis 3(3): e401. Doi:10.1371/journal.pntd.0000401.
Borlase, A, Blumberg, S., Callahan, E. K., Deiner, M. S., Nash, S. D., Porco, T. C., Solomon, A. W., Lietman, T. M., Prada, J. M. and Hollingsworth, T. D. (2021) Modelling Trachoma Post-2020: Opportunities for Mitigating the Impact of COVID-19 and Accelerating Progress towards Elimination. Trans R Soc Trop Med Hyg, Vol. 115: pp 213–221. Doi:10.1093/trstmh/traa171.
References
Blake, I. M., Burton, M. J., Bailey, R. L., Solomon, A. W., West, S., et al., (2009) Estimating Household and Community Transmission of Ocular Chlamydia trachomatis. PLoS Negl Trop Dis 3(3): e401. Doi:10.1371/journal.pntd.0000401.
Borlase, A, Blumberg, S., Callahan, E. K., Deiner, M. S., Nash, S. D., Porco, T. C., Solomon, A. W., Lietman, T. M., Prada, J. M. and Hollingsworth, T. D. (2021) Modelling Trachoma Post-2020: Opportunities for Mitigating the Impact of COVID-19 and Accelerating Progress towards Elimination. Trans R Soc Trop Med Hyg, Vol. 115: pp 213–221. Doi:10.1093/trstmh/traa171.
THANK YOU
FOR
YOUR
TIME